Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Pharmacokinetics of Afamelanotide in Patients With Erythropoietic Protoporphyria (EPP)

NCT06388642 is registered in ClinicalTrials.gov with Clinuvel Europe Limited as lead sponsor.

NCT NCT06388642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06388642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Pharmacokinetics of Afamelanotide in Patients With Erythropoietic Protoporphyria (EPP)
Lead sponsor
Clinuvel Europe Limited
Phase
Phase 1/2
Overall status
Completed
Start date
March 7, 2024
Completion date
January 20, 2025
Enrollment
28 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

erythropoietic protoporphyria